Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
4 hedge funds and large institutions have $832K invested in Biocept, Inc. in 2014 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
15% less capital invested
Capital invested by funds: $982K → $832K (-$150K)
20% less funds holding
Funds holding: 5 → 4 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GBA
Garrison Bradford & Associates
New York
|
-$80.6K |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
-$72K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GBA
1
Garrison Bradford & Associates
New York
| $333K | -$80.6K | -1 | -17% |
|
2
Verition Fund Management
Greenwich,
Connecticut
| $215K | – | – | – |
|
|
PCM
3
Perkins Capital Management
Wayzata,
Minnesota
| $178K | – | – | – |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $73K | – | – | – |
|
|
CP
5
Camelot Portfolios
Maumee,
Ohio
| $25K | – | – | – |
|
|
MFS
6
MSI Financial Services
Springfield,
Massachusetts
| $4K | – | – | – |
|
7
Citigroup
New York
| $2K | – | – | – |
|
8
Morgan Stanley
New York
| $2K | – | – | – |
|
|
LP
9
LMR Partners
London,
United Kingdom
| – | -$72K | -1 | Closed |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| – | -$1K | – | – |
|
BIOC Hedge Fund Activity: Q4 2014 in Review
4 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q4 2014, worth a combined $832K — down 15% from $982K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BIOC and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Garrison Bradford & Associates, cutting an estimated $80.6K.
- 4 institutional investors held Biocept, Inc. (BIOC) as of Q4 2014, down from 5 in Q3 2014.
- Funds reported $832K of Biocept, Inc. stock for Q4 2014, down 15% quarter-over-quarter.
- 0 funds opened new Biocept, Inc. positions in Q4 2014 and 1 closed out, a net change of -1 holder.
- The largest Biocept, Inc. seller in Q4 2014 was Garrison Bradford & Associates, an estimated $80.6K sold.
Based on aggregated 13F filings for Q4 2014.